Elizabeth Barrett
2022
In 2022, Elizabeth Barrett earned a total compensation of $1.9M as Chief Executive Officer at UroGen Pharma Ltd., a 56% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $307,449 |
|---|---|
| Option Awards | $753,195 |
| Salary | $764,290 |
| Other | $45,626 |
| Total | $1,870,560 |
Barrett received $764.3K in salary, accounting for 41% of the total pay in 2022.
Barrett also received $307.4K in non-equity incentive plan, $753.2K in option awards and $45.6K in other compensation.
Rankings
In 2022, Elizabeth Barrett's compensation ranked 1,872nd out of 5,756 executives tracked by ExecPay. In other words, Barrett earned more than 67.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,872 out of 5,756 | 68th |
Division Manufacturing | 986 out of 3,133 | 69th |
Major group Chemicals And Allied Products | 409 out of 1,419 | 71st |
Industry group Drugs | 374 out of 1,320 | 72nd |
Industry Pharmaceutical Preparations | 268 out of 966 | 72nd |
Source: SEC filing on August 1, 2023.
Barrett's colleagues
We found two more compensation records of executives who worked with Elizabeth Barrett at UroGen Pharma Ltd. in 2022.